A Conversation Between David Collingridge and Henryk Barthel
J Nucl Med
.
2020 Mar;61(3):307-310.
doi: 10.2967/jnumed.120.243311.
Authors
David Collingridge
1
,
Henryk Barthel
2
Affiliations
1
The Lancet Oncology, London, United Kingdom; and.
2
Leipzig University, Leipzig, Germany.
PMID:
32123130
DOI:
10.2967/jnumed.120.243311
No abstract available
Publication types
Interview
MeSH terms
Animals
Humans
Neoplasms / diagnostic imaging
Neoplasms / radiotherapy
Nuclear Medicine*